ClinicalTrials.gov
public full text
Public Domain
STRADIVARIUS (Strategy To Reduce Atherosclerosis Development InVolving Administration of Rimonabant - the Intravascular Ultrasound Study)
The purpose of this study is to determine if rimonabant 20 mg once daily (od) administered during 18-20 months will reduce progression of coronary atherosclerosis as assessed by intravascular ultrasound (IVUS) when administered on top of standard behavioral and pharmacological therapy given as needed, in patients with abdominal obesity associated with current smoking and/or metabolic syndrome.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Drug Therapy Induced Weight Loss to Improve Blood Vessel Function in Subjects With Obesity#668944
- Oral Curcumin Supplementation in Middle-Aged and Older Adults Improves Vascular Function#1088314
- Reduktion der Strahlendosis im Verlauf bei einem neuen interventionellen Verfahren am Beispiel der Prostataarterienembolisation (PAE) / Rabea Maria Wentz ; Betreuer: Christian R. Habermann#970282
- A Study to Assess the Effect of a High Fat Meal on Surufatinib in Healthy Subjects#968705
- Uso de plantas medicinales para el tratamiento del síndrome metabólico#675140
Record · ID 1031137
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive